Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer

Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer

Boman Dhabhar Department of Medical Oncology, Fortis Hospital, Mumbai, IndiaCorrespondence: Boman Dhabhar, Consultant, Medical Oncology, Fortis Hospital, Mulund, Mumbai, 400078, Maharashtra, India, Email drboman@hotmail.comAbstract: Chemotherapeutic agents, endocrine therapy and radiotherapy used in...

Full description

Bibliographic Details
Main Author: Dhabhar B
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Breast Cancer: Targets and Therapy
Subjects:
nonmetastatic breast cancer
postmenopausal women
denosumab
bone loss
bone mineral density
fracture
Online Access:https://www.dovepress.com/cancer-treatment-induced-bone-loss-role-of-denosumab-in-non-metastatic-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/cancer-treatment-induced-bone-loss-role-of-denosumab-in-non-metastatic-peer-reviewed-fulltext-article-BCTT

Similar Items